CN1069203C - Drug for curing diabetes - Google Patents
Drug for curing diabetes Download PDFInfo
- Publication number
- CN1069203C CN1069203C CN96114614A CN96114614A CN1069203C CN 1069203 C CN1069203 C CN 1069203C CN 96114614 A CN96114614 A CN 96114614A CN 96114614 A CN96114614 A CN 96114614A CN 1069203 C CN1069203 C CN 1069203C
- Authority
- CN
- China
- Prior art keywords
- shares
- medicine
- parts
- radix
- ginseng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The present invention relates to a Chinese herbal medicine, more specifically a traditional Chinese medicine which has a prevention and treatment effect on diabetes. A main prescription comprises 5 to 10 shares of milk vetch, 2 to 6 shares of ginseng, 5 to 10 shares of snakegourd root, 5 to 10 shares of common anemarrhena rhizome, 4 to 10 shares of kudzuvine root, 4 to 10 shares of radix asparagi, 4 to 10 shares of Chinese magnoliavine fruit, 4 to 10 shares of single ginseng, 3 to 10 shares of polygonatum and 3 to 10 shares of medicine. An auxiliary medicine comprises 2 to 6 shares of chitin. Side effects brought by the existing medicine treating method for orally taking and injecting insulin does not exist in the medicine, patients can conveniently take the medicine, and a preparation method of the present invention is simple and practical. The medicine can be taken for a long time without any toxic or side effect, and the medicine solves the problem brought by that diabetic patients with poor liver, heart and kidney functions can not take hypoglycemic western medicines.
Description
The present invention relates to Chinese herbal medicine, specifically a kind of Chinese medicine that diabetes is had prevention and therapeutical effect.
For treatment of diabetes, normally adopt insulin injection and oral sulfonylurea and biguanides oral medicine.Medicine clinically can only be effective to the mild or moderate diabetics that pancreatic function does not completely lose, and is relatively poor to juvenile form and severe diabetics curative effect.If taking dose is careless slightly, may cause allergic reaction or hypoplastic anemia, the patient who has also gastrointestinal reaction can occur, as feeling sick vomiting, inappetence, organs such as Liver and kidney also directly there is detrimental effect, so the bad diabetics of hepatic and renal function is definitely prohibited clothes.Insulin also can cause allergic reaction and local irritant reaction except that can causing the side effect that oral drugs cause, and red and swollen scleroma etc. can appear in the subcutaneous injection part.Make the insulinize patient also have the dependency of strong row, be difficult to lose in case use.No matter use which kind of Western medicine all easily to cause microangiopathies, toxic and side effects is serious.
The objective of the invention is shortcoming, provide a kind of therapeutic effect good, be easy to take and have no side effect, diabetes are had the Chinese medicine of better prevention and therapeutic effect at above-mentioned existence.
The object of the present invention is achieved like this: it comprises main formula agent and accessory drugs, and the formation of main formula agent (by weight) is: 5～10 parts of the Radixs Astragali, 2～6 parts of Radix Ginsengs, 5～10 parts of Radix Trichosanthis, 5～10 parts of the Rhizoma Anemarrhenaes, 4～10 parts of Radix Puerariaes, 4～10 parts of Radix Asparagis, 4～10 parts of Fructus Schisandrae Chinensis, 4～10 parts of Radix Salviae Miltiorrhizaes, 3～10 parts of Rhizoma Polygonati Odorati, 3～10 parts of RHIIZOMA DIOSCOREAE frOm Henan of China.Accessory drugs (by weight) is 2～6 parts of chitins.
With the Radix Astragali of main formula agent, Radix Ginseng, Radix Trichosanthis, the Rhizoma Anemarrhenae, Radix Puerariae, Radix Asparagi, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae, Rhizoma Polygonati Odorati, Chinese yam powder is broken to 60～80 orders, dress bubble bag; The accessory drugs chitin is a powder packets.
It is 10～12 grams that bubble bag weight is adorned in the main formula agent, and accessory drugs powder packets weight is 2～4 grams.
The medicine that the present invention is given do not have side effect oral before and that the insulin injection pharmacotherapy is brought, and patient's medication is convenient, and its preparation method is simple.Take without any side effectsly for a long time, particularly the bad diabeticss of function such as those livers, heart, kidney can be taken for a long time, solved liver, the heart, the bad diabetics of renal function and can not obey the drawback that the blood sugar lowering Western medicine is brought.The decapacitation of this medicine is eliminated outside the clinical symptoms, also can pass through physiological rhythm, the body immune function, and blood sugar lowering, glucose in urine recover body function rapidly.
Embodiment:
1. get 10 parts of the Radixs Astragali, 6 parts of Radix Ginsengs, 10 parts of Radix Trichosanthis, 10 parts of Radix Puerariaes, 10 parts of Radix Asparagis, 10 parts of Fructus Schisandrae Chinensis, 10 parts of Radix Salviae Miltiorrhizaes, 10 parts of Rhizoma Polygonati Odorati, 10 parts of RHIIZOMA DIOSCOREAE frOm Henan of China are crushed to 60 orders and are principal agent by 10 gram amounts dress bubble bag; Powdery chitin (chitin chitosan) for accessory drugs, constitutes major-minor prescription by 2 gram amounts dress.
Principal agent is decoction made from powder 10 gram bubble bag drink-services, is advisable to steep to drink after meal; Accessory drugs 2 grams are powder (powder is planar) drink-service separately, every day three times, are advisable during with dining.
2. get the Radix Astragali by weight, Radix Ginseng, Radix Trichosanthis, Radix Puerariae, Radix Asparagi, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae, Rhizoma Polygonati Odorati, each 5 parts of RHIIZOMA DIOSCOREAE frOm Henan of China are crushed to 80 orders and pack (principal agent) by 12 gram amounts, and chitin constitutes accessory drugs by 3 gram amounts dress bag, and instructions of taking is with example 1.
Claims (2)
1. medicine for the treatment of diabetes is characterized in that it comprises main formula agent and accessory drugs:
A. the main formula agent is by weight: 5～10 parts of the Radixs Astragali, 2～6 parts of Radix Ginsengs, 5～10 parts of Radix Trichosanthis, 5～10 parts of the Rhizoma Anemarrhenaes, 4～10 parts of Radix Puerariaes, 4～10 parts of Radix Asparagis, 4～10 parts of Fructus Schisandrae Chinensis, 4～10 parts of Radix Salviae Miltiorrhizaes, 3～10 parts of Rhizoma Polygonati Odorati, 3～10 parts of RHIIZOMA DIOSCOREAE frOm Henan of China;
B. accessory drugs is: 2～6 parts of chitins.
2. according to the preparation method of the described medicine of claim 1, it is characterized in that the Radix Astragali with the main formula agent, Radix Ginseng, Radix Trichosanthis, the Rhizoma Anemarrhenae, Radix Puerariae, Radix Asparagi, Fructus Schisandrae Chinensis, Radix Salviae Miltiorrhizae, Rhizoma Polygonati Odorati, Chinese yam powder is broken to 60～80 orders, dress bubble bag; The accessory drugs chitin is a powder packets.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96114614A CN1069203C (en) | 1996-12-12 | 1996-12-12 | Drug for curing diabetes |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN96114614A CN1069203C (en) | 1996-12-12 | 1996-12-12 | Drug for curing diabetes |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1184640A CN1184640A (en) | 1998-06-17 |
| CN1069203C true CN1069203C (en) | 2001-08-08 |
Family
ID=5122190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN96114614A Expired - Fee Related CN1069203C (en) | 1996-12-12 | 1996-12-12 | Drug for curing diabetes |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1069203C (en) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010084486A (en) * | 2000-02-25 | 2001-09-06 | 정두순 | Method of manufacturing herbal medicine for lowering hypoglycemic treatment of diabetes |
| US20070020346A1 (en) * | 2005-05-03 | 2007-01-25 | Hongtao Xing | Botanical anticancer formulations |
| CN1977884B (en) * | 2005-12-08 | 2010-05-26 | 天津中新药业集团股份有限公司乐仁堂制药厂 | Medicinal composition for treating diabetes and its preparing method |
| CN105663898A (en) * | 2016-03-07 | 2016-06-15 | 黄鹏 | Chinese herbal medicine formula for treating diabetes |
| CN105920294A (en) * | 2016-04-28 | 2016-09-07 | 甘肃省中医药研究院 | Traditional Chinese medicine composition for treating diabetes and its preparation method and use |
| CN106166227A (en) * | 2016-08-27 | 2016-11-30 | 桂林七星粉业有限责任公司 | A kind of processing technique of the fragrant solomonseal health-care powder with blood sugar decreasing effect |
| CN109568489A (en) * | 2018-12-18 | 2019-04-05 | 漳州市吾梓贸易有限公司 | A kind of Chinese medicine composition and preparation method thereof for treating diabetes |
| CN113599457A (en) * | 2021-09-25 | 2021-11-05 | 赣州药食同源健康管理有限公司 | A Chinese medicinal composition for treating diabetes, and its preparation method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1063613A (en) * | 1992-02-29 | 1992-08-19 | 河北省遵化县制药厂 | The preparation method of Yuquan capsule |
| CN1106271A (en) * | 1994-02-01 | 1995-08-09 | 张树成 | Method for prepn. of medicinal introducing bag for treating diabetes mellitus |
-
1996
- 1996-12-12 CN CN96114614A patent/CN1069203C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1063613A (en) * | 1992-02-29 | 1992-08-19 | 河北省遵化县制药厂 | The preparation method of Yuquan capsule |
| CN1106271A (en) * | 1994-02-01 | 1995-08-09 | 张树成 | Method for prepn. of medicinal introducing bag for treating diabetes mellitus |
Non-Patent Citations (3)
| Title |
|---|
| 四川中医1986，4(8) 1986.1.1 闻永淑:加减天花散治疗消渴症36例 * |
| 四川中医1986，4(8) 1986.1.1 闻永淑:加减天花散治疗消渴症36例;浙江中医杂志1985，20(3) 1985.1.1 刘延即:王液汤加味治疗糖尿病25例 * |
| 浙江中医杂志1985，20(3) 1985.1.1 刘延即:王液汤加味治疗糖尿病25例 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1184640A (en) | 1998-06-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101642529B (en) | Preparation capable of treating diabetes | |
| CN102271698B (en) | Pharmaceutical composition and use for preparing medicament thereof | |
| CN102028900A (en) | Traditional Chinese medicine for treating metabolic syndrome and preparation method thereof | |
| CN102065874B (en) | Compositions for reducing blood glucose level and uses thereof | |
| CN101352539A (en) | Composite of Chinese traditional medicine for diabetes mellitus | |
| CN1069203C (en) | Drug for curing diabetes | |
| CN1046633C (en) | Compound melbine capsule and making process | |
| CN103830674A (en) | Medicament composition for treating lipomyoma and preparation method and application thereof | |
| CN1137720C (en) | Chinese medicine for treating diabetes and its complication | |
| CN101623485B (en) | Dan e women-healthcare granulae | |
| CN101352551A (en) | Medicament for treating liver disease | |
| CN1049128C (en) | Antidiarrheal powder for baby | |
| CN110368469A (en) | Join glue stilbene particle drink | |
| CN1097322A (en) | Oral liquid for decreasing blood sugar and compound method thereof | |
| CN1616041A (en) | Chinese medicine composition for treating chronic ulcerative colitis | |
| CN1110922A (en) | Navel medicine bag for treatment of indigestion and child digestive disorder and its prepn. | |
| CN1660339A (en) | 'Sanxiaoling' capsule | |
| CN107519261A (en) | A kind of Chinese medicine composition for treating leukaemia and preparation method thereof | |
| CN1306830A (en) | Medicine for treating Type-11 diabetes | |
| CN101637573B (en) | Medicinal composition for treating diabetes and preparation method thereof | |
| CN1072940C (en) | Oral liquid for anti-cancer | |
| CN1291722C (en) | Use of oligoxylose in preparing medicine for treating diabetes | |
| CN104888068A (en) | Medicine for treatment or adjuvant treatment of acquired immune deficiency syndrome and preparation method and application method of medicine | |
| CN1091026A (en) | Danshixiao medicine for treating cholelithiasis | |
| CN1113443A (en) | Xiaokekang bath powder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |